Results 81 to 90 of about 96,180 (101)

Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry

Journal of Hepatology, 2021
Ismael Álvarez-Álvarez, Manuel Romero-Gómez, Eva Roman   +2 more
exaly  

Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice

Antioxidants, 2021
Cristiana Freixo, Maria Isabel Lucena Gonzalez   +1 more
exaly  

The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment

Metabolites, 2022
Marta Moreno Torres, Guillermo Quintás, José V Castell   +2 more
exaly  

Idiosyncratic DILI and RUCAM under One Hat: The Global View

Livers, 2023
Gaby Danan, Rolf Teschke
exaly  

Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)—In Vitro Testing

Pharmaceutics, 2023
Peter Tátrai, Peter Krajcsi
exaly  

Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes

Archives of Toxicology, 2021
Teresa Martínez-Sena, Eugenia Pareja, Guillermo Quintás   +2 more
exaly  

Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review

Expert Opinion on Drug Metabolism and Toxicology, 2021
Ismael Álvarez-Álvarez, Gerd A Kullak-Ublick, Edmond Atallah   +2 more
exaly  

Recurrent Drug-Induced Liver Injury (DILI) with different drugs in the Spanish Registry: The dilemma of the relationship to autoimmune hepatitis

Journal of Hepatology, 2011
Marina Berenguer, Hacibe Hallal
exaly  

Global Epidemiology of Drug-Induced Liver Injury (DILI)

Current Hepatology Reports, 2019
Einar Björnsson
exaly